1. Dong RP, Kimura A, Okubo R, Shinagawa H, Tamai H, Nishimura Y, Sasazuki T (1992) HLA-A
and DPB1 loci confer susceptibility to Graves’ disease. Hum Immunol 35:165–172
2. Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K (1997) CTLA4 Alanine-17 confers genetic susceptibility to Graves’ disease and to type I diabetes mellitus. J Clin Endocrinol Metab 82:143–146
3. Heward JM, Allahabadia A, Armitage M, Hattersley A, Dodson PM, Macleod K, Carr-Smith J, Daykin J, Daly A, Sheppard MC, Holder RL, Barnett AH, Franklyn JA, Gough SC (1999) The development of Graves’ disease and the CTLA4 gene on chromosome 2q33. J Clin Endocrinol Metab 84:2398–2401
4. Kotsa K, Watson PF, Weetman AP (1997) A CTLA4 gene polymorphism is associated with both Graves’ disease and autoimmune hypothyroidism. Clin Endocrinol 46:551–554
5. Risch N (1990) Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 46:229–241